H. Seidel et H. Sperschneider, ESTIMATION OF DIFFERENT LABORATORY PARAME TERS FOR VALUATION OF IRON-METABOLISM IN HEMODIALYSIS-PATIENTS, Nieren- und Hochdruckkrankheiten, 27(5), 1998, pp. 215-222
In hemodialysis patients (HD) for the treatment of anemia estimation o
f iron balance is very important. There are discrepant opinions regard
ing the value of zinc protoporphyrin (ZPP), the percentage of hypochro
mic red blood cells (%Hypo), serum ferritin (SF) and transferrin satur
ation (TFS) with respect to aluminum (Al) overloading. We estimated in
77 HD (56 +/- 16 years) the parameter SE TFS, %Hypo and ZPP monthly d
uring a 6-month period without iron therapy and after a 4-month period
with iron therapy. The second period was firstly started with a iron
test dosis of 125 mg i.v. 43 HD were treated by rhEPO with a stable do
sage during 10 months. Desferrioxamin(DFO)-test were carried out at th
e beginning, after 6 months and at the end of the study. During the pe
riod without iron therapy 63 HD (81.8%) developed a manifest iron defi
ciency documented by significant increase of %Hypo (1.49% to 3.50%), Z
PP (96 to 104 mu mol/mol heme) and decrease of the SF (846 to 502 mu g
/l) and TFS (30.1% to 16.4%). The increase of %Hypo was obvious in iro
n deficiency and in Al-overloading too (p < 0.01). A bolus application
of 125 mg iron i.v. yielded an increase of %Hypo (108% after 1 week)
and obviously significant (p < 0.01) correlation regarding (r = 0.88)
the increase of hemoglobin during iron therapy. ZPP gave no evidence i
n diagnosis of iron deficiency in renal anemia. %Hypo seems to be a mu
ch more potent predictor value assuming that an Al-overload is exclude
d.